Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 16,829 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric Lefkofsky sold 16,829 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total value of $1,102,972.66. Following the transaction, the chief executive officer directly owned 2,003,213 shares in the company, valued at $131,290,580.02. The trade was a 0.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Tempus AI Stock Performance

Tempus AI stock traded down $3.40 during mid-day trading on Thursday, hitting $65.69. 7,149,431 shares of the company’s stock traded hands, compared to its average volume of 6,352,496. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. The firm has a 50 day simple moving average of $83.96 and a two-hundred day simple moving average of $71.87. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The stock has a market cap of $11.69 billion, a price-to-earnings ratio of -55.20 and a beta of 4.86.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.05. The firm had revenue of $334.21 million for the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company’s quarterly revenue was up 84.7% on a year-over-year basis. During the same period in the previous year, the company earned ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. On average, research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Victory Capital Management Inc. boosted its position in shares of Tempus AI by 1.5% during the 3rd quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock worth $894,000 after acquiring an additional 162 shares in the last quarter. Global Retirement Partners LLC lifted its stake in Tempus AI by 29.5% during the third quarter. Global Retirement Partners LLC now owns 733 shares of the company’s stock worth $59,000 after purchasing an additional 167 shares during the last quarter. US Bancorp DE boosted its holdings in shares of Tempus AI by 6.6% in the 3rd quarter. US Bancorp DE now owns 2,848 shares of the company’s stock valued at $230,000 after purchasing an additional 176 shares in the last quarter. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Tempus AI by 0.7% in the 2nd quarter. China Universal Asset Management Co. Ltd. now owns 33,757 shares of the company’s stock valued at $2,145,000 after purchasing an additional 226 shares in the last quarter. Finally, SeaCrest Wealth Management LLC increased its stake in shares of Tempus AI by 3.7% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 6,488 shares of the company’s stock valued at $524,000 after purchasing an additional 229 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on TEM shares. HC Wainwright cut their price objective on shares of Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research report on Friday, November 7th. Piper Sandler dropped their price target on Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a report on Tuesday, November 11th. Needham & Company LLC boosted their price target on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Guggenheim increased their price objective on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 26th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $80.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.